[1]
Meena, R., Biswas, N., Kumar, L., Velpandian, T. and Gupta, Y. 2011. Safety Profile of Imatinib in Indian Chronic Myeloid Leukemia Patients. Health Renaissance. 9, 1 (Mar. 2011), 24–30. DOI:https://doi.org/10.3126/hren.v9i1.4358.